NDC 0310-4535 – Imjudo
Tremelimumab 300 mg/15mL · Injection, Solution · Intravenous
Product NDC0310-4535
Product details
- Brand name
- Imjudo
- Generic name
- Tremelimumab
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761289
- Marketed since
- October 21, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- CTLA-4-directed Blocking Antibody
Active ingredients
- Tremelimumab 300 mg/15mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0310-4535-30 | 1 VIAL in 1 CARTON (0310-4535-30) / 15 mL in 1 VIAL | Oct 21, 2022 |
Other Imjudo products
- 0310-4505 Tremelimumab 25 mg/1.25mL · Injection, Solution · AstraZeneca Pharmaceuticals LP